Lactation studies of anticonvulsants: A quality review

British Journal of Clinical Pharmacology

Volumn 79, Issue 4, 2015, Pages 558-565

  Van Der Meer, Douwe H ^a   Wieringa, Andre ^a   Wegner, Ilse ^b   Wilffert, Bob ^a,c   Ter Horst, Peter G J ^a  

^a Isala Hospitals   (Netherlands)

^b STICHTING EPILEPSIE INSTELLINGEN NEDERLAND SEIN   (Netherlands)

^c UNIVERSITY OF GRONINGEN   (Netherlands)

Author keywords

anti epileptic drugs; anticonvulsants; breast milk; human milk; lactation

Indexed keywords

ANTICONVULSIVE AGENT; CARBAMAZEPINE; CLOBAZAM; CLONAZEPAM; ESLICARBAZEPINE; ETHOSUXIMIDE; ETIRACETAM; GABAPENTIN; HARKOSERIDE; LAMOTRIGINE; OXCARBAZEPINE; PHENOBARBITAL; PHENYTOIN; PRIMIDONE; RETIGABINE; RUFINAMIDE; STIRIPENTOL; TOPIRAMATE; VALPROIC ACID; VIGABATRIN;

ABSOLUTE INFANT DOSE; ANALYTICAL PARAMETERS; BREAST MILK; DRUG ABSORPTION; DRUG BLOOD LEVEL; DRUG CONCENTRATION; DRUG DISTRIBUTION; DRUG DOSE; DRUG MILK LEVEL; FOOD AND DRUG ADMINISTRATION; HUMAN; LACTATION; MATERNAL PLASMA; MEDICAL SOCIETY; MILK TO PLASMA RATIO; PRACTICE GUIDELINE; PRIORITY JOURNAL; REVIEW; BLOOD; CHEMISTRY; EUROPE; FEMALE; INTERNATIONAL COOPERATION; METABOLISM; NEWBORN; UNITED STATES;

ANTICONVULSANTS; EUROPE; FEMALE; HUMANS; INFANT, NEWBORN; INTERNATIONAL AGENCIES; LACTATION; MILK, HUMAN; PRACTICE GUIDELINES AS TOPIC; UNITED STATES; UNITED STATES FOOD AND DRUG ADMINISTRATION;

EID: 84925400269     PISSN: 03065251     EISSN: 13652125     Source Type: Journal    
DOI: 10.1111/bcp.12524     Document Type: Review

References (93)

1. Kramer MS, Kakuma R,. Optimal duration of exclusive breastfeeding. Cochrane Database Syst Rev 2012; (8) CD003517.
2. Chung M, Raman G, Trikalinos T, Lau J, Ip S,. Interventions in primary care to promote breastfeeding: an evidence review for the U.S. Preventive Services Task Force. Ann Intern Med 2008; 149: 565-582.
3. Breastfeeding and the use of human milk. Pediatrics 2012; 129: e827-841.
4. Centers for Disease Control and Prevention. Breastfeeding report card-United States. 2012.
5. Yerby MS,. Quality of life, epilepsy advances, and the evolving role of anticonvulsants in women with epilepsy. Neurology 2000; 55 (5 Suppl. 1): S21-31; discussion S54-8.
6. Knott C, Reynolds F, Clayden G,. Infantile spasms on weaning from breast milk containing anticonvulsants. Lancet 1987; 2: 272-273.
7. Frey B, Braegger CP, Ghelfi D,. Neonatal cholestatic hepatitis from carbamazepine exposure during pregnancy and breast feeding. Ann Pharmacother 2002; 36: 644-647.
8. Merlob P, Mor N, Litwin A,. Transient hepatic dysfunction in an infant of an epileptic mother treated with carbamazepine during pregnancy and breastfeeding. Ann Pharmacother 1992; 26: 1563-1565.
9. Fisher JB, Edgren BE, Mammel MC, Coleman JM,. Neonatal apnea associated with maternal clonazepam therapy: a case report. Obstet Gynecol 1985; 66 (3 Suppl.): 34S-35.
10. Nordmo E, Aronsen L, Wasland K, Småbrekke L, Vorren S,. Severe apnea in an infant exposed to lamotrigine in breast milk. Ann Pharmacother 2009; 43: 1893-1897.
11. Finch E, Lorber J,. Methaemoglobinaemia in the newborn probably due to phenytoin excreted in human milk. J Obstet Gynaecol Br Emp 1954; 61: 833-834.
12. Chen L, Liu F, Yoshida S, Kaneko S,. Is breast-feeding of infants advisable for epileptic mothers taking antiepileptic drugs? Psychiatry Clin Neurosci 2010; 64: 460-468.
13. Begg EJ, Duffull SB, Hackett LP, Ilett KF,. Studying drugs in human milk: time to unify the approach. J Hum Lact 2002; 18: 323-332.
14. Food and Drug Administration. Clinical lactation studies-study design, data analysis and recommendations for labeling. 2005.
15. Akus M, Bartick M,. Lactation safety recommendations and reliability compared in 10 medication resources. Ann Pharmacother 2007; 41: 1352-1360.
16. Page-Sharp M, Kristensen JH, Hackett LP, Beran RG, Rampono J, Hale TW, Kohan R, Ilett KF,. Transfer of lamotrigine into breast milk. Ann Pharmacother 2006; 40: 1470-1471.
17. Kristensen JH, Ilett KF, Hackett LP, Kohan R,. Gabapentin and breastfeeding: a case report. J Hum Lact 2006; 22: 426-428.
18. Newport DJ, Pennell PB, Calamaras MR, Ritchie JC, Newman M, Knight B, Viguera AC, Liporace J, Stowe ZN,. Lamotrigine in breast milk and nursing infants: determination of exposure. Pediatrics 2008; 122: e223-231.
19. Pynnönen S, Kanto J, Sillanpää M, Erkkola R,. Carbamazepine: placental transport, tissue concentrations in foetus and newborn, and level in milk. Acta Pharmacol Toxicol (Copenh) 1977; 41: 244-253.
20. Horning M, Stillwell W, Nowlin J, Lertratanangkoon K, Stillwell R, Hill R,. Identification and quantification of drugs and drug metabolites in human breast milk using GC-MS-COM methods. Mod Probl Paediatr 1975; 15: 73-79.
21. Tran A, O'Mahoney T, Rey E, Mai J, Mumford JP, Olive G,. Vigabatrin: placental transfer in vivo and excretion into breast milk of the enantiomers. Br J Clin Pharmacol 1998; 45: 409-411.
22. Hall B,. Changing composition of human milk and early development of an appetite control. Lancet 1975; 305: 779-781.
23. Ilett KF, Lebedevs TH, Wojnar-Horton RE, Yapp P, Roberts MJ, Dusci LJ, Hackett LP,. The excretion of dothiepin and its primary metabolites in breast milk. Br J Clin Pharmacol 1992; 33: 635-639.
24. Kemp J, Ilett KF, Booth J, Hackett LP,. Excretion of doxepin and N-desmethyldoxepin in human milk. Br J Clin Pharmacol 1985; 20: 497-499.
25. Rampono J, Hackett LP, Kristensen JH, Kohan R, Page-Sharp M, Ilett KF,. Transfer of escitalopram and its metabolite demethylescitalopram into breastmilk. Br J Clin Pharmacol 2006; 62: 316-322.
26. Kristensen JH, Ilett KF, Hackett LP, Yapp P, Paech M, Begg EJ,. Distribution and excretion of fluoxetine and norfluoxetine in human milk. Br J Clin Pharmacol 1999; 48: 521-527.
27. Verbeeck RK, Ross SG, McKenna EA,. Excretion of trazodone in breast milk. Br J Clin Pharmacol 1986; 22: 367-370.
28. Kristensen JH, Ilett KF, Rampono J, Kohan R, Hackett LP,. Transfer of the antidepressant mirtazapine into breast milk. Br J Clin Pharmacol 2007; 63: 322-327.
29. European Medicine Agency. Guideline on risk assessment of medicinal products on human reproduction and lactation: from data to labelling. 2009.
30. Piontek CM, Baab S, Peindl KS, Wisner KL,. Serum valproate levels in 6 breastfeeding mother-infant pairs. J Clin Psychiatry 2000; 61: 170-172.
31. Stahl MM, Neiderud J, Vinge E,. Thrombocytopenic purpura and anemia in a breast-fed infant whose mother was treated with valproic acid. J Pediatr 1997; 130: 1001-1003.
32. Clark CT, Klein AM, Perel JM, Helsel J, Wisner KL,. Lamotrigine dosing for pregnant patients with bipolar disorder. Am J Psychiatry 2013; 170: 1240-1247.
33. Precourt A, Morin C,. Use of lamotrigine during breastfeeding: descriptive analysis of our population and report of five cases of premature neonates. Breastfeed Med 2011; 6 (Suppl.): S-18.
34. Cibert M, Gouraud A, Vial T, Tod M,. A physiologically-based pharmacokinetic model to predict neonate exposure to drugs during breast-feeding: application to lamotrigine. Fundam Clin Pharmacol 2010; 24 (Suppl.): 1-106.
35. Kacirova I, Grundmann M, Brozmanova H,. Serum levels of lamotrigine in breastfeeding mothers, maternal milk and nursed infants. Basic Clin Pharmacol Toxicol 2011; 109 (Suppl. 4): 1-176.
36. Pote M, Kulkarni R, Agarwal M,. Phenobarbital toxic levels in a nursing neonate. Indian Pediatr 2004; 41: 963-964.
37. Birnbaum CS, Cohen LS, Bailey JW, Grush LR, Robertson LM, Stowe ZN,. Serum concentrations of antidepressants and benzodiazepines in nursing infants: A case series. Pediatrics 1999; 104: e11.
38. Wisner KL, Perel JM,. Serum levels of valproate and carbamazepine in breastfeeding mother-infant pairs. J Clin Psychopharmacol 1998; 18: 167-169.
39. Hibberd CM, Brooke OG, Carter ND, Haug M, Harzer G,. Variation in the composition of breast milk during the first 5 weeks of lactation: implications for the feeding of preterm infants. Arch Dis Child 1982; 57: 658-662.
40. Pynnonen S, Sillanpaa M,. Carbamazepine and mother's milk. Lancet 1975; 2: 563.
41. Kaneko S, Sato T, Suzuki K,. The levels of anticonvulsants in breast milk. Br J Clin Pharmacol 1979; 7: 624-627.
42. Niebyl JR, Blake D, Freeman JM, Luff RD,. Carbamazepine levels in pregnancy and lactation. Obstet Gynecol 1979; 53: 139-140.
43. Kuhnz W, Jäger-Roman E,. Carbamazepine and carbamazepine-10, 11-epoxide during pregnancy and postnatal period in epileptic mother and their nursed infants: pharmacokinetics and clinical effects. Pediatr Pharmacol 1983; 3: 199-208.
44. Froescher W, Eichelbaum M, Niesen M, Dietrich K, Rausch P,. Carbamazepine levels in breast milk. Ther Drug Monit 1984; 6: 266-271.
45. Meyer F, Quednow B, Potrafki A, Walther H,. [The perinatal pharmacokinetics of anticonvulsant drugs]. Zentralbl Gynakol 1988; 110: 1195-1205.
46. Brent NB, Wisner KL,. Fluoxetine and carbamazepine concentrations in a nursing mother/infant pair. Clin Pediatr (Phila) 1998; 37: 41-44.
47. Lopes BR, Barreiro JC, Baraldi PT, Cass QB,. Quantification of carbamazepine and its active metabolite by direct injection of human milk serum using liquid chromatography tandem ion trap mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci 2012; 889-890: 17-23.
48. Shimoyama R, Ohkubo T, Sugawara K,. Monitoring of carbamazepine and carbamazepine 10,11-epoxide in breast milk and plasma by high-performance liquid chromatography. Ann Clin Biochem 2000; 37 (Pt 2): 210-215.
49. Kacirova I, Grundmann M, Brozmanova H,. Therapeutic monitoring of carbamazepine concentrations in breastfeeding mothers, maternal milk and nursed infants. Ther Drug Monit 2011; 33: 503.
50. Koup J, Rose J, Cohen M,. Ethosuximide pharmacokinetics in a pregnant patient and her newborn. Epilepsia 1977; 19: 535-539.
51. Rane A, Tunell R,. Ethosuximide in human milk and in plasma of a mother and her nursed infant. Br J Clin Pharmacol 1981; 12: 855-858.
52. Kuhnz W, Koch S, Jakob S, Hartmann A, Helge H, Nau H,. Ethosuximide in epileptic women during pregnancy and lactation period. Placental transfer, serum concentrations in nursed infants and clinical status. Br J Clin Pharmacol 1984; 18: 671-677.
53. Tomson T, Villén T,. Ethosuximide enantiomers in pregnancy and lactation. Ther Drug Monit 1994; 16: 621-623.
54. Soderman P, Rane A,. Ethosuximide and nursing. Acta Pharm 1986; 59 (Suppl.): Abstract 513.
55. Westerink D, Glerum JH,. [Separation and microdetermination of phenobarbital and phenytoin in human milk]. Pharm Weekbl 1965; 100: 577-583.
56. Gomita Y, Furuno K, Araki Y, Yamatogi Y, Ohtahara S,. Phenobarbital in sera of epileptic mothers and their infants. Am J Ther 1995; 2: 968-971.
57. Shimoyama R, Ohkubo T, Sugawara K,. Characteristics of interaction between barbiturate derivatives and various sorbents on liquid chromatography and determination of phenobarbital in Japanese human breast milk. J Liq Chromatogr Relat Technol 2000; 23: 587-599.
58. Kuhnz W, Koch S, Helge H, Nau H,. Primidone and phenobarbital during lactation period in epileptic women: total and free drug serum levels in the nursed infants and their effects on neonatal behavior. Dev Pharmacol Ther 1988; 11: 147-154.
59. Mirkin B,. Diphenylhydantoin: Placental transport, fetallocalization, neonatal metabolism, and possible teratogenic effects. J Pediatr 1971; 78: 329-337.
60. Rane A, Garle M, Borga O, Sjoqvist F,. Plasma disappearance of transplacentally transferred diphenyl-hydantoin in the newborn studied by mass fragmentography. Clin Pharmacol Ther 1974; 15: 39-45.
61. Shimoyama R, Ohkubo T,. Monitoring of phenytoin in human breast milk, maternal plasma and cord blood plasma by solid-phase extraction and liquid chromatography. J Pharm Biomed Anal 1998; 17: 863-869.
62. Sugawara K, Shimoyama R, Ohkubo T,. Determinations of psychotropic drugs and antiepileptic drugs by high-performance liquid chromatography and its monitoring in human breast milk. Hirosaki Med J 1999; 51 (Suppl.): 81-86.
63. Soderman P, Matheson I,. Clonazepam in breast milk. Eur J Pediatr 1988; 147: 212-213.
64. Steen B, Rane A, Lönnerholm G, Falk O, Elwin CE, Sjöqvist F,. Phenytoin excretion in human breast milk and plasma levels in nursed infants. Ther Drug Monit 1982; 4: 331-334.
65. Ohman I, Vitols S, Tomson T,. Lamotrigine in pregnancy: pharmacokinetics during delivery, in the neonate, and during lactation. Epilepsia 2000; 41: 709-713.
66. Rambeck B, Kurlemann G, Stodieck SR, May TW, Jürgens U,. Concentrations of lamotrigine in a mother on lamotrigine treatment and her newborn child. Eur J Clin Pharmacol 1997; 51: 481-484.
67. Tomson T, Ohman I, Vitols S,. Lamotrigine in pregnancy and lactation: a case report. Epilepsia 1997; 38: 1039-1041.
68. Berry D,. The disposition of lamotrigine throughout pregnancy. Ther Drug Monit 1999; 21: 450.
69. Ohman I, Tomson T, Vitols S,. Lamotrigine (LTG) pharmacokinetics during delivery and lactation. Ther Drug Monit 1999; 21: 478.
70. Fotopoulou C, Kretz R, Bauer S, Schefold JC, Schmitz B, Dudenhausen JW, Henrich W,. Prospectively assessed changes in lamotrigine-concentration in women with epilepsy during pregnancy, lactation and the neonatal period. Epilepsy Res 2009; 85: 60-64.
71. Kacirova I, Grundmann M, Brozmanova H,. Drug interaction between lamotrigine and valproic acid used at delivery and during lactation-a case report. Basic Clin Pharmacol Toxicol 2011; 109 (Suppl.): 56-164.
72. Kacirova I, Grundmann M, Koristkova B, Brozmanova H,. Therapeutic monitoring of lamotrigine during delivery, in the neonatal period, and during lactation. Ther Drug Monit 2007; 29: 477.
73. Alexander F,. Sodium valproate in pregnancy. Arch Dis Child 1979; 54: 240-245.
74. Dickinson R, Harland RC, Lynn RK, Smith WB, Gerber N,. Transmission of valproic acid (Depakene) across the placenta: Half-life of the drug in mother and baby. J Pediatr 1979; 94: 832-835.
75. Von Unruh G, Froescher W, Hoffmann F, Niesen M,. Valproic acid in breast milk: how much is really there? Ther Drug Monit 1984; 6: 272-276.
76. Nau H, Koch S, Häuser I, Helge H,. Valproic acid and its metabolites: placental transfer, neonatal pharmacokinetics, transfer via mother's milk and clinical status in neonates of epileptic mothers. J Pharmacol Exp Ther 1981; 219: 768-777.
77. Nau H, Helge H, Luck W,. Valproic acid in the perinatal period: decreased maternal serum protein binding results in fetal accumulation and neonatal displacement of the drug and some metabolites. J Pediatr 1984; 104: 627-634.
78. Philbert A, Pedersen B, Dam M,. Concentration of valproate during pregnancy, in the newborn and in breast milk. Acta Neurol Scand 1985; 72: 460-463.
79. Tsuru N, Maeda T, Tsuruoka M,. Three cases of delivery under sodium valproate. Placental transfer, milk transfer and probable teratogenicity of sodium valproate. Jpn J Psychiatry Neurol 1988; 42: 89-96.
80. Ohman I, de Flon P, Tomson T,. Pregabalin kinetics in the neonatal period, and during lactation. Epilepsia 2011; 52: 23-263.
81. Ohman I, Vitols S, Tomson T,. Pharmacokinetics of gabapentin during delivery, in the neonatal period, and lactation: does a fetal accumulation occur during pregnancy? Epilepsia 2005; 46: 1621-1624.
82. Ohman I, Tomson T,. Gabapentin kinetics during delivery, in the neonatal period, and during lactation. Epilepsia 2009; 50 (Suppl.): 108.
83. Kramer G, Hosli I, Glanzmann R,. Levetiracetam accumulation in human breast milk. Epilepsia 2002; 43 (Suppl.): 105.
84. Greenhill L, Betts T, Yarrow H, Patsalos P,. Breast milk levels of levetiracetam after delivery. Epilepsia 2004; 45 (Suppl.): 230.
85. Johannessen SI, Helde G, Brodtkorb E,. Levetiracetam concentrations in serum and in breast milk at birth and during lactation. Epilepsia 2005; 46: 775-777.
86. Tomson T, Palm R, Källén K, Ben-Menachem E, Söderfeldt B, Danielsson B, Johansson R, Luef G, Ohman I,. Pharmacokinetics of levetiracetam during pregnancy, delivery, in the neonatal period, and lactation. Epilepsia 2007; 48: 1111-1116.
87. Bulau P, Paar W, von Unruh G,. Pharmacokinetics of oxcarbazepine and 10-hydroxy-carbazepine in the newborn child of an oxcarbazepine-treated mother. Eur J Clin Pharmacol 1988; 34: 311-313.
88. Lutz U, Wiatr G, Gaertner H, Bartels M,. Oxcarbazepine treatment during breast-feeding: a case report. J Clin Psychopharmacol 2007; 27: 730-732.
89. Ohman I, Tomson T,. Pharmacokinetics of oxcarbazine in neonatal period and during lactation. Epilepsia 2009; 50 (Suppl. 4): 2-262.
90. Nau H, Rating D, Häuser I, Jäger E,. Placental transfer and pharmacokinetics of primidone and its metabolites phenobarbital, PEMA and hydroxyphenobarbital in neonates and infants of epileptic mothers. Eur J Clin Pharmacol 1980; 18: 31-42.
91. Ohman I, Vitols S, Luef G, Söderfeldt B, Tomson T,. Topiramate kinetics during delivery, lactation, and in the neonate: preliminary observations. Epilepsia 2002; 43: 1157-1160.
92. Westergren T, Hjelmeland K, Kristoffersen B, Johannessen SI, Kalikstad B,. Topiramate-induced diarrhoea in a 2-month-old breastfed child. Drug Saf 2009; 32: 875-993.
93. Froscher W, Jurges U,. [Topiramate used during breast feeding]. Aktuelle Neurol 2006; 33: 215-217.